Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
bbio
/
BridgeBio Pharma Inc
BBIO
Add to Watchlist
84.030
USD
+1.100
+1.33%
Close 07-23 16:00(ET)
Quotes delayed by 15 min
84.020
USD
+84.020
After-hours (ET)
16.45B
Market Cap
Loss
P/E TTM
BridgeBio Pharma Inc
84.030
+1.100
+1.33%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Kohlberg Kravis Roberts & Co. L.P.
6.77%
BlackRock Institutional Trust Company, N.A.
6.16%
Viking Global Investors LP
6.05%
Janus Henderson Investors
5.62%
Farallon Capital Management, L.L.C.
4.59%
Other
70.81%
Shareholders
Shareholders
Proportion
Kohlberg Kravis Roberts & Co. L.P.
6.77%
BlackRock Institutional Trust Company, N.A.
6.16%
Viking Global Investors LP
6.05%
Janus Henderson Investors
5.62%
Farallon Capital Management, L.L.C.
4.59%
Other
70.81%
Shareholder Types
Shareholders
Proportion
Investment Advisor
36.99%
Investment Advisor/Hedge Fund
35.07%
Hedge Fund
13.21%
Private Equity
8.58%
Individual Investor
3.92%
Research Firm
3.06%
Venture Capital
1.32%
Sovereign Wealth Fund
0.78%
Pension Fund
0.46%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
793
195.09M
99.61%
-1.32M
2025Q4
692
193.26M
104.83%
+271.46K
2025Q3
709
193.09M
107.21%
-2.36M
2025Q2
651
195.61M
105.27%
+8.34M
2025Q1
612
193.54M
102.70%
-1.78M
2024Q4
570
182.80M
101.77%
+5.04M
2024Q3
551
177.77M
103.84%
-1.98M
2024Q2
526
180.27M
100.67%
+2.80M
2024Q1
514
177.44M
98.44%
-3.39M
2023Q4
509
170.23M
101.76%
+4.36M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Kohlberg Kravis Roberts & Co. L.P.
13.26M
6.84%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
12.07M
6.23%
+152.45K
+1.28%
Dec 31, 2025
Viking Global Investors LP
13.03M
6.72%
-1.37M
-9.50%
Feb 13, 2026
Janus Henderson Investors
11.00M
5.67%
+2.26M
+25.85%
Dec 31, 2025
Farallon Capital Management, L.L.C.
9.00M
4.64%
+806.46K
+9.84%
Dec 31, 2025
Kumar (Neil)
6.18M
3.19%
+5.67K
+0.09%
Feb 19, 2026
Aisling Capital Management LP
5.09M
2.63%
-1.00M
-16.42%
Dec 31, 2025
State Street Investment Management (US)
4.96M
2.56%
-643.47K
-11.48%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Tema Oncology ETF
5.74%
Franklin Genomic Advancements ETF
4.69%
Invesco Dorsey Wright Healthcare Momentum ETF
2.6%
Virtus LifeSci Biotech Products ETF
2.53%
State Street SPDR S&P Biotech ETF
2.32%
Tema Heart & Health ETF
2.06%
ProShares Ultra Nasdaq Biotechnology
1.67%
Direxion Daily S&P Biotech Bull 3X Shares
1.43%
iShares Health Innovation Active ETF
1.36%
Invesco Nasdaq Biotechnology ETF
1.17%
View more
Tema Oncology ETF
Proportion
5.74%
Franklin Genomic Advancements ETF
Proportion
4.69%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion
2.6%
Virtus LifeSci Biotech Products ETF
Proportion
2.53%
State Street SPDR S&P Biotech ETF
Proportion
2.32%
Tema Heart & Health ETF
Proportion
2.06%
ProShares Ultra Nasdaq Biotechnology
Proportion
1.67%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
1.43%
iShares Health Innovation Active ETF
Proportion
1.36%
Invesco Nasdaq Biotechnology ETF
Proportion
1.17%